BackMetacrine Overview

Metacrine Other Current Assets

Latest other current assets for MTCR: $2.2M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$2.23M
41.08% YoYΔ $-1.55M vs prior year quarter

Peer average

Loading

Metacrine Other Current Assets History

Loading

Metacrine vs. peers: Other Current Assets Comparison

Loading

Metacrine Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Metacrine (MTCR) FAQ

As of the most recent data (September 2022), MTCR shows a other current assets of $2.2M. That compares with $3.8M in the prior-year period — down 41.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MTCR's other current assets is now $2.2M (was $3.8M) — a 41.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Metacrine is outperforming or lagging.

Tracking MTCR's other current assets over time shows whether Metacrine is scaling, shrinking, or reshaping that part of the business. The current reading is $2.2M That compares with $3.8M in the prior-year period — down 41.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Metacrine's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $2.2M) with ownership activity and broader fundamentals.

Metacrine's other current assets is $2.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.